Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics

[Image: see text] Cyclin-dependent kinase 6 (CDK6) is linked with a cyclin partner and plays a crucial role in the early stages of cancer development. It is currently a potential drug target for developing therapeutic molecules targeting cancer therapy. Here, we have identified taurine as an inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousuf, Mohd, Shamsi, Anas, Mohammad, Taj, Azum, Naved, Alfaifi, Sulaiman Y. M., Asiri, Abdullah M., Mohamed Elasbali, Abdelbaset, Islam, Asimul, Hassan, Md Imtaiyaz, Haque, Qazi Mohd Rizwanul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330843/
https://www.ncbi.nlm.nih.gov/pubmed/35910117
http://dx.doi.org/10.1021/acsomega.2c03479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330843/
https://www.ncbi.nlm.nih.gov/pubmed/35910117
http://dx.doi.org/10.1021/acsomega.2c03479

Ejemplares similares